Publisher
Wiley-VCH Verlag GmbH & Co. KGaA
Reference36 articles.
1. Vascular Endothelial Growth Factor as a Target for Anticancer Therapy
2. Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3
3. Kania , R.S. Bender , S.L. Borchardt , A.J. Braganza , J.F. Cripps , S.J. Hua , Y. Johnson , M.D. Johnson , T.O. , Jr. Luu , H.T. Palmer , C.L. Reich , S.H. Tempczyk-Russell , A.M. Teng , M. Thomas , C. Varney , M.D. Wallace , M.B. 2001
4. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
5. The Heck Reaction as a Sharpening Stone of Palladium Catalysis
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献